 Hi, good afternoon everybody. My name is Daniel Lavek. I head up SAP and IT Solutions for Zulek Pharma. Today I'd like to run you through basically some of the work we've been doing around blockchain, especially in the material traceability in the pharma supply chain here in Asia. So really there's two parts to the presentation today. Myself, I will run to the the solution that we have and basically some of the use cases which we have in place in the region and then I'll handle it to my colleague Haishen who will take you through more technical on the architecture and basically the vision roadmap of where we hope to take the solution. So really before I jump in, let me just give a little overview of who Zulek Pharma are. We're a privately owned Swiss family owned company based out of Asia, originally headquartered out of the Philippines. We've been in around and established for close to 100 years and we have roughly 13,000 employees across 13 countries in Asia and last year we hit roughly $14 billion in sales revenue. By nature we are a pharma distributor and so what we do is we distribute pharmaceutical products for the key pharma manufacturers and the distribution is a key part of our business but we do have a number of other services that we offer around our distribution and we do things like clinical reach, we have commercial solutions where we take products under license and we have Care Connect where we look at things around peer services and HMOs and insurance and then underpinning that we have our analytics business which really is looking at all of the data points that we capture along the supply chain and how we can use those to kind of help our clients make better and faster decisions. As I say we are in 13 countries in Asia. We are in a pretty unique position in Asia in that we have quite large coverage in a lot of the markets that we are actually dealing and as you can see Philippines is one of our biggest markets there and also we have, as I said, we are a distributor for the top pharma manufacturers in the world and you can see that the majority of the top 20 or 30 that we list there we distribute for them and across multiple markets that we actually do business in. So really what I wanted to talk about today is really around what we've been trying to do in the supply chain traceability space and really Asia is a very different market or place than some of the US or Europe for what we see in here. You know there's a huge issue with counterfeits in this region. It's estimated World Health Organization says between one in ten it could be up to three in ten of products that come into the market here either counterfeit or substandard and obviously that has a huge impact on people's lives but also on lost revenue and so yeah anyway up to three billion dollars currently being lost in revenue and counterfeit medicines in Southeast Asia alone. There's also quite a large problem you might say our prevalence around cross-border trading of great markets so basically products that are sold in one market end up turning up in another market and so really that brings with it a whole risk of a whole raft of issues around how did they get there how were they transported are these cold chain products where they were they transported in the right conditions not to mention that there's a monetary value attached to that as well. Obviously there's a margin of erosion there's inefficiencies in the supply chain there's obviously each handover point the data can be lost basically and so really how do we how do we streamline that whole supply chain how do we how do we give a window into the the visibility and how do we share data efficiently across the supply chain. When we originally started this idea about putting a blockchain solution in place it was really to help facilitate product recalls and product recalls in the pharma industry and in the space take a long time they can take anything between two to three months to figure out where all the products are and get everything in place and then try to try to pull them all back how can we put a solution in place where the click of a button you can you can quarantine products and know exactly where everything where everything is and then obviously there's this is not something that can be ignored now this it's high on everybody's agenda this we see from interactions with authorities such as Interpol and UN organized German crime that are really being able to to get or target counterfeits in in this this area is key in a top agenda so how can we how can we help in that fight. So really it's a pretty simple or straightforward solution as as what we were looking at really if we look at our our supply chain we have raw materials supplies we have manufacturers we have ourselves distributors and then we have the the channels of where they go through that hospital clinic and then at the end the patient but really how can we how can we bring all of these players together all these parties in what this tends to be a fragmented ecosystem together and help and get people everybody too to participate in in a network in effect and so one there's the first challenge that we saw was being able to share information between parties you know there's no there's no standardized format there's no mechanism for data transfer there's also a lack of let's say trust people don't want to send data or the data ownership so how can we how can we make or offer a solution where where we take those those kind of pain points aware we then saw the the second challenge was really to be able to to track a product's activity from end to end along the supply chain so really get information passed over consistently being able to record that information in a timely manner and being able to to to give whoever needs access to that that data a window into it without with it being able to overcome the challenges of sharing information and then the third challenge was how do you give this access to patient how can we empower a patient to be able to to through a mobile phone and look into into the supply chain and make a decision or a choice before they are they take a joke or before they are vaccinated that this is a maybe genuine is a is a hard word to to be able to to kind of prove but to be at least able to say that it came through a verified supply chain and and we have confidence that that this product has has been passed through and the handoff points have been added to be controlled along along the supply chain so early in a nutshell the solution is is a is a two or three part solution depending on how we want to look at it and it's if you break it down in these basic parts it really is a mobile app that allows a patient to scan a data matrix qr code and on medication and be able to trace right the way back to to the the origin of that particular product where it was manufactured where it came from where it's been how long it was in certain locations where was it stored in the in the right temperature controls and and that that it's been through a supply chain and being handled in the correct way and so as I mentioned it really it just all it does is transform a mobile phone patient's mobile phone into a verification tool and very very straightforward scan you get a you get a result and we run it on a show so it's all cloud-based and so what we're doing is the solution itself it sits on on hypoallergenic fabric and it really is a very easy way a non-intrusive way to allow patients to to see the provenance of a drug by scanning a code on the box and so what we've started to look at this is all very nice and so we obviously have an ecology assurance for for patients but then is there any other key stakeholders that that we can also help by having the solution in place and so really how do we look at our our key farmer manufacturers or our key clients there to help them with with certain areas which are maybe pain points in in their business and so really obviously straight up is really being able to to work with them on pharmacovigilants to track products from from plant to down to the patient then is the is there other things that we can do around around wastage and cost maybe we can do in retrievability we can do VMI we can start to do auto replenishments and really a big one that we started seeing is obviously around the brand trust and so basically being able to strengthen that brand trust and and really allow them to to kind of give a sample of approval to say okay the products that we have they're going through EasyTracker we work in there we know that you can be assured that these are these are genuine products they've been to a genuine supply chain and they've been handled in the correct way so really kind of using that as as a as a rubber stump to say I see if you scan with this with the EasyTracker product you're good to go obviously patience is a key one and really it is about empowering the patient to to make a choice that the product that they're about to take is is good and they can have a confidence that that they can go ahead and take that and again yeah checking that it's a genuine medication but also the quality and then really if if there is an issue with that that product after they say they've scanned it how can they report any any issue so if there's any advance adverse events or for instance product recalls how can we how can we very quickly notify a patient because we know that they scanned it to say look you have to return that product because because there's something wrong with it and then the third one was really how can we better work with with with healthcare organizations so really how can we how can we start to to use this this blockchain network that we we've built up to say okay is there is other things we can do around inventory management again around the BMI or auto replenishment how can we maybe look at if we take it one step further about looking at payments so really if you can if you can start to facilitate a a a network where we can guarantee that the the product is is genuine as it's been through a supply chain it's the quality is okay it's been delivered can you then start to to work on some sort of auto financing so that that we can tick all the boxes and then you can start to release a payment or you can work on some sort of integrated financing solution that that that can help with the the efficiencies in healthcare and so really in a nutshell I think as I explained there's there's key players that we have in the in the ecosystem and each of those players has their own blockchain node and and and it feeds into the blockchain network and basically what we're trying to do or what we are doing is is that a patient has a as a mobile app they scan the code as you can see and they get one of three answers it's a genuine product you're good to go it's unregistered it's it's not a product that we find anywhere on the blockchain even though it looks like a genuine code and and yeah in all intention purposes the package is genuine and it looks like a real product or there's a third one that we see is is a parallel product so really this this was a genuine product it went through the supply chain but it's in a place where it it shouldn't be and that could be a different country it could also be a different facility for instance we can go down to the level to say okay this was um this was sold to a government hospital but actually you're scanning it in a in a private clinic and we're not sure how we got there so really really getting a granular level of detail and being able to to share that with the patient one area that is really around this digital identity um you know this this is um in Asia we don't have a so far we don't have a serialization mandate that that is across across Asia and we it's not like what we see happening in the US and what we see kind of happening in Europe here if we take only only Korea has has serialization but this makes the solution a little bit more difficult to be able to to to give the level of granularity that that we want to to to make it a much more usable system and so as part of our our warehousing process what we actually do is is assign a digital identity to each of the products that are that are actually loaded into to the blockchain and into an available on EasyTracker and what that does is it allows us to then tag individual boxes to individual people who have been sold to and then back to and then obviously then tie that back to the patient so it gives us a much lower level of granularity that that we would usually get if we were working with say um products on a on a batch level um and so very very simple we have kind of three three main areas which we we target in the in the EasyTracker solution one is obviously traceability and all about being able to use blockchain to help um secure the supply chain and and flag if there's if there's any issues any any falsified or counterfeits or any cross borders. Strengthening is really about um around helping uh farmer clients um to to basically strengthen their their products if there is any any any issues or anything that that's flagged through the app then how do we then take the next step and how do we pass this off to the the necessary authorities so that they can do something about it and then there's an education piece as well because within the app if you scan a product we can obviously then then put some some key points around why you should take the product education around what potentially might be side effects and also if you if you scan a counterfeit product what what could be the the impact if you were to if you were to to take that product and so finally before I'm over to um to actually to go through uh some of the more technical details really I want to just touch on a few of the um a few of the uh the kind of the use cases or success stories that that we we've have up and running um and so one is it's um we've we've worked very closely with our partner Accenture to really pioneer build the Asia's first blockchain that worked for for pharmaceutical and healthcare clients and really this is this is how we've started to um how we did this was was really work together we we obviously went through a design thinking approach partnering with with Accenture and we've developed a hyper ledger blockchain integration framework and we've worked on a on an API layer and really enhancing the data and the communications between uh between between components and then we're now in the process of really starting to to ramp this open and on board uh on board pharmaceutical clients and really it is obviously the first um first blockchain network of its of its kind in in Asia um second one is really this is uh something that that that we we're kind of live with now with and it's really this this all builds in um to some of the work that we've done already with with MSD uh on on their products but really it's it's a nice extension if you like to build out um to to the next level so we've already worked closely with MSD and Zulip Farmer for for products in in Hong Kong how can we then build in the next step in the ecosystem which would really bring in a clinic management uh provider and and bring in a chain of clinics to then then capture that data and so really how do we we work in in a partnership to to bring that together and really really yeah so really how do we how do we kind of start to build out the the blockchain network from from uh to bring all players into into the ecosystem and so this was a key objective or strategic objective of where we wanted to take the the blockchain network and and so this is in our opinion a very very big step uh in in building out the ecosystem and then really the the the um use case that really kicked it off was was um the when we started this in 2019 was um we had an issue or there was an issue in Hong Kong where there was um counterfeit HPV vaccines being administered and so we we worked closely with MSD to to kind of build a solution which would allow um allow them to overcome this and and really what it was to to bring MS MSD Gardasil 9 vaccines into the blockchain and then allow the app to be able to scan them and for them to be able for the patient to be able to to to get the result before they were vaccinated and so really this this is uh I often get asked is this a kind of a pilot or is it a POC but this is a real life um deployment it's live there's people who have downloaded the downloaded the the app as you can see they're close to 20,000 have the app running and we've had so far more than 40,000 scans of the of the product and we it's going very very successfully and we had to keep evolving the product along along the way you know we haven't moved towards better technology around being able to secure the the data matrix codes make them anti-temp approved make sure that that they can't be copied or kind of reused but very successful um so far and that's allowed us to build on um with with the additional use cases and kind of start to build out this this ecosystem so with that I will hand over to my colleague Haisheng and he will go through the the the technical architecture for easy okay okay thank you Daniel maybe can I share my screen yeah okay then you can you see my screen now yes yeah okay thank you Daniel uh so in here our our two things one is our technical architecture another one is our roadmap in the future so as Dan said uh currently we are in our production so how it works in very high level uh high level architect so we yeah so uh down the way from supplier until the end user uh the the clinic and the end user we are onboarding all of almost all of them in our hyperlater fabric blockchain you can see currently we we are onboarding some of the manufacturers including MSD uh gutter cell uh gutter right so in here in the manufacturer they will share the uh the view of feeding the material batching information including the uh the batch info the expirational data all of the other mesh data to the blockchain but of course before that there are some off data meaning uh not all of the information will be fed into the blockchain ledger data instead there might be some their own private data so uh we only feeding the evidence for the traceability purpose because after that the data for the traceability will be shared along the network blockchain network to all of the participants in the in the network so this including the uh distributor like a distributor like Azulifama or the other distributor and the HCL hospital clinic as well as the uh the end user yeah so when the product reach the uh the warehouse in Azulifama we will also feeding more information in the blockchain uh some one thing is the uh the good traceability information the update like we will be tracing uh this data to we will be shipping this data this uh messing to the to the hospital or clinic another thing is the uh security information like the coaching information as well as the other the other things we will feed in this information into the blockchain and then down the way to the clinic the clinic will also do some uh stock repository management as well as the patient information the patient vaccination management so so you can see down the way except for the supplier side so down the way we are sharing all of the information in the blockchain network so all of the uh note all of the organization will see some portion of the of the information not all because of the some privacy some confidential and uh legal appliance reason so how do we do this so this is a very detailed architecture I will spend like uh three hours to go through every detail so I won't do that because um in technical or point of view this is quite a quite a common quite a normal design but still there are some highlights I want to I want to mention here so one is we have the connection between the existing system to our blockchain network so meaning we will feed in the data from your existing system uh in our case it is a SAP HANA database for the other case we can we can get data from either their open service or their database or even there are just some excel files to upload to the uh to the file server right so we have our uh defined well defined the ETL system to to load the data to our often often database as well as the blockchain ledger data those things we will share we are sharing our API so that for the easy track app for the end user for the Zoic the warehouse operator and for the other partners or the other software company to consume all the other manufacturer or the other participant to consume our API you know as a as a service right so we will you know send the data to the blockchain the in the blockchain how do we build this blockchain even in very short time there are two key points one is the AKS class the AKS so we are built up this everything in Asia Microsoft Azure cloud with uh Kubernetes service this is one thing another thing that we use the uh the the buff the blockchain automation framework released by uh Accenture to do the automated uh deployment so this buff is super strong it can support the coda etrium a hyper ledger fabric to deploy in any of the cloud so uh cloud uh provide the Asia AWS and the GCP as well as the on-premise service uh yeah so that means we can we are able to support the uh all the other participant to host their own node there in their own info in very easy way but uh so one thing to I want to mention is that so for now we can provide the main service from Zulik site you know we can you know we can uh host everything for the clinic because they don't have the technique capacity or they don't have time to build up that or they don't want to build up from their side so we will help them to build up the everything for them for the clinical for the other uh participants so after we build up that we will have to operate on this uh node as well the same time we can also allow the other uh participant to build up their own info so I just take this AWS as an example you can do that in whatever other cloud so this uh info is just a uh some replicate of the uh everything from the Asia cloud only they don't need to set up their own network instead they only just need to set up the node from their side the node uh the the API service of chain database even even the message queue everything so uh when they set up the info from their side they we will share the information from the blockchain uh from the blockchain layer so what are the information shared across the blockchain uh for current we have uh basically the three big uh categories what is the medicine information the vaccination the medicine uh the the traceability information the other thing is the quality uh information such as the uh expiry data uh the coaching temperature information uh in real time and also also have the clinic inform clinic connection to help the clinic to to uh keep the patient information and the stock information so these are the three major information uh to see in the later but still you know uh Daniel said we are in production but still we are in very young age we only uh you know uh deployed that in production in like a half years ago so what is our vision so I will share that in two two side one is who uh what kind of solution we can provide for the end user for the participant another one is how what what kind of participant can be uh can get help uh can get benefit from this uh blockchain network so one thing is uh the material traceability information so this is our foundation for the user tracker blockchain so we will have the manufacturer the clinic the hospital and the the distributor to maintain the to trace and track the material and also help uh the patient to to see whether this is the genuine or counterfeit to do the authenticity check and the quality assurance information such as the empire data and the coaching information this is very very important especially we will be tracing the uh COVID-19 vaccine so this uh I mean all of the uh vaccine will be kept in very good storage condition so we should keep a very uh secure condition for this uh medicine another thing is for the patient safety I mean among among all of these things patient yeah among all of these things patient security is the number one uh yeah literally the number number one important things for us to do in the blockchain world so we want to make sure the patient can use the the medicine in very secure way so anytime if there are anything wrong with the medicine we will be uh you know uh messaging the patient to do the you know the call back and to alert the patient for any potential risk so this is the the number one important thing for the blockchain uh to do the last but not the least uh in the future we will have the participant to do the finance uh since we will reduce the the paperwork we will increase the return of the cash then we will you know save the money for the for the participant then in in the future we will uh you know help the the patient uh to to to do more things so these are the solution we can provide for the participant and so who will be be get benefit from our blockchain so almost all of the uh participant all all all of the guys from the supply chain supply chain ecosystem can get benefit from us so including the farm manufacturers the distributors uh as well as some even the Zuli farmers are competitors the distributors where houses and the other pharmacists retailer and the clinic and hospitals so all of them will be able to be onboarding in the blockchain network easy tracker blockchain network and also we will provide more solution for each every single participant so that we can attract the more participants to be onboarding our blockchain network and then you know the participants should also get benefit from our very very big network so that you know we can expand the network and also we will be working very closely with the other blockchain uh pharmaceutical blockchain network such as the media ledger from the u.s and the farmer ledger from europe so after so this inter ledger cross ledger cross blockchain solution is it is just a steel uh in the uh under construction but in the future we will be working very closely with this uh this other network you know to enhance our solution to to give a very uh big even bigger ecosystem yeah so this of easy tracker so as as i said steel uh easy tracker blockchain is in our efficiency uh period still it's only half years old right we are very still still we are very young we are small but in the future we will be helping the the whole world to you know to reduce the diseases to to increase the uh the health condition so our be our dream is very big so i think that's all for my side uh so thank you very much uh if you are yeah you're more than welcome to ask question you hear and also to learn more things from our website yeah that's all thank you thank you very much okay thank you i think that's all let me see are there any other questions yeah okay thank you i think that's all our our uh share the answer for the questions on for offline thank you